Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
The crystal and cryo-EM structures of PLCγ2 reveal dynamic interdomain recognitions in autoinhibition.
Shin YC et al.
Science Advances, 2024
The cytokine FAM3B/PANDER is an FGFR ligand that promotes posterior development in Xenopus.
Zhang F et al.
Proceedings of the National Academy of Sciences of the United States of America, 2021
33975953 (PubMed )
Supplement: pnas.2100342118.sapp.pdf
Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes.
Liu Y et al.
Ebiomedicine, 2020
Nuclear magnetic resonance analysis of the conformational state of cancer mutant of fibroblast growth factor receptor 1 tyrosine kinase domain.
Kobashigawa Y et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2016
Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domain.
Kobashigawa Y et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2015
Structural and functional integration of the PLCγ interaction domains critical for regulatory mechanisms and signaling deregulation.
Bunney TD et al.
Structure (london, England : 1993), 2012
23063561 (PubMed )
Supplement: mmc1.pdf
Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.
Zou L et al.
The Journal of Biological Chemistry, 2012
Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function.
Persaud A et al.
The Embo Journal, 2011
21765395 (PubMed )
Supplement: 44318_2011_BFEMBJ2011234_MOESM1_ESM.pdf
Select a paper to view details